By continuing to use the site you agree to our Privacy & Cookies policy

Old drug offers new hope of tailored pancreatic cancer treatment

A failed pancreatic cancer treatment could be resurrected as a personalised medicine aimed at one in five patients with the disease, research suggests.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo